Antimicrobial stewardship approaches urgently need to be reinforced during the COVID-19 pandemic. This study evaluates the impact of the COVID-19 on antibiotic consumption
Description of the Study:
- Title: Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern
- Principal investigator: Gabriela Abelenda Alonso, Ariadna Padullés, Alexander Rombauts, Carlota Gudiol, Miquel Pujol, Claudia Alvarez Pouso, Ramón Jodar and Jordi Carratalà.
- Centers of Implementation: Hospital Universitari de Bellvitge, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona and Spanish Network for Research in Infectious Diseases, Madrid.
- Study Population: Patients admitted in Hospital Universitari de Bellvitge from January 1 to April 30 in 2019 and 2020.
- Study Type: Before-and-after cross-sectional study.
- Design: Before-and-after cross-sectional study comparing data in 2019 (before the COVID-19 pandemic began) and 2020 (COVID-19) for the periods from January 1 to April 30.
- Methods: Medians for continuous variables were compared using the Wilcoxon log-rank test.
Objectives of the Study:
Principal Objective: To calculate the defined daily dose per 100 patient days, and based on the dispensing data of an electronic prescribing system.
More about this Study:
Scientific Context: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a public health problem of historic dimensions. However, this pandemic is occurring in the setting of an antimicrobial resistance crisis that is increasing at an alarming pace worldwide.
Conclusions: Standardizing immunomodulatory treatments, ensuring compliance with usual infection control practices, and carefully interpreting microbiological results will be key measures that could favor a more cautious approach to the use of antibiotics.
In this study a biphasic pattern of increased antibiotic use was identified and that corresponded with a first wave of empirical antibiotic therapy and a second biphasic pattern with higher use of broad-spectrum antibiotics.
Data support the World Health Organization concern regarding inappropriate use of antibiotics during the pandemic and the recent change in its guidelines discouraging empirical antibiotics in COVID-19.
Hospital Universitari de Bellvitge: It is a 700-bed hospital that serves as a public referral center of 1 million inhabitants in Catalonia, the second worst pandemic-affected area in Spain. As of April 30, 2020, this hospital had had >1,293 hospital admissions for COVID-19, with a 317% increase in critical care bed use.
Other studies about Pharmacology:
This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.
CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.
This study aims to determine the effects of vaccination against SARS-CoV-2 in people with long COVID.
This study suggests that primary care diagnosis and treatment with antihistamines, plus azithromycin in selected cases, may treat COVID-19 and prevent progression to severe disease in elderly patients.
Solidarity is an international clinical trial to evaluate the effect of a number of drugs for the treatment of COVID-19.
A study to determine if influenza vaccination or ACEI or ARB medication has effects on COVID-19.
The Col-VID study aims to determine whether the use of colchicine reduces the severity or even prevents death in patients with COVID-19.
Can sex hormones help men survive COVID-19? This study assesses the safety and efficacy of progesterone for the treatment of COVID-19 in hospitalized men.
Open, randomized, adaptive, phase III clinical trial study to evaluate the efficacy of various pharmacological alternatives in the treatment of severe infection in COVID-19 pediatric patients.